Vitamin D Receptor Activation and Left Ventricular Hypertrophy in Advanced Kidney Disease

2011 ◽  
Vol 33 (2) ◽  
pp. 139-149 ◽  
Author(s):  
Ravi Thadhani ◽  
Evan Appelbaum ◽  
Yuchiao Chang ◽  
Yili Pritchett ◽  
Ishir Bhan ◽  
...  
2013 ◽  
Vol 28 (11) ◽  
pp. 2735-2744 ◽  
Author(s):  
S. Panizo ◽  
S. Barrio-Vazquez ◽  
M. Naves-Diaz ◽  
N. Carrillo-Lopez ◽  
I. Rodriguez ◽  
...  

2009 ◽  
Vol 297 (6) ◽  
pp. F1502-F1509 ◽  
Author(s):  
José M. Valdivielso ◽  
Jorge Cannata-Andía ◽  
Blai Coll ◽  
Elvira Fernández

Vitamin D has proven to be much more than a simple “calcium hormone.” The fact that the vitamin D receptor has been found in cells not related to mineral metabolism supports that statement. The interest of nephrologists in vitamin D and its effects beyond mineral metabolism has increased over the last few years, evidencing the importance of this so-called “sunshine hormone.” In the present review, we highlight the most recent developments in the traditional use of vitamin D in chronic kidney disease (CKD) patients, namely, the control of secondary hyperparathyroidism (sHPT). Furthermore, we also explore the data available regarding the new possible therapeutic uses of vitamin D for the treatment of other complications present in CKD patients, such as vascular calcification, left ventricular hypertrophy, or proteinuria. Finally, some still scarce but very promising data regarding a possible role of vitamin D in kidney transplant patients also are reviewed. The available data point to a potential beneficial effect of vitamin D in CKD patients beyond the control of mineral metabolism.


2012 ◽  
Vol 164 (6) ◽  
pp. 902-909.e2 ◽  
Author(s):  
Hector Tamez ◽  
Carmine Zoccali ◽  
David Packham ◽  
Julia Wenger ◽  
Ishir Bhan ◽  
...  

Nutrients ◽  
2014 ◽  
Vol 6 (3) ◽  
pp. 1029-1037 ◽  
Author(s):  
Domenico Santoro ◽  
Giorgia Gagliostro ◽  
Angela Alibrandi ◽  
Riccardo Ientile ◽  
Guido Bellinghieri ◽  
...  

2022 ◽  
Vol 23 (1) ◽  
Author(s):  
Bingman Liu ◽  
Qingqing Yang ◽  
Liangyu Zhao ◽  
Hua Shui ◽  
Xiaoyun Si

Abstract Background To verify that the single nucleotide polymorphisms (SNP) of vitamin D receptor (VDR) may lead to genetic susceptibility to left ventricular hypertrophy (LVH), the present study was designed to study four SNPs of VDR associated with LVH in maintenance hemodialysis (MHD) patients of Han nationality. Methods 120 MHD patients were recruited at Department of Nephrology, Zhongnan Hospital of Wuhan University to analyze the expression of genotype, allele and haplotype of Fok I, Bsm I, Apa I and Taq I in blood samples, and to explore their correlation with blood biochemical indexes and ventricular remodeling. Results The results showed that the risks of CVD included gender, dialysis time, heart rate, SBP, glycated hemoglobin, calcium, iPTH and CRP concentration. Moreover, LAD, LVDd, LVDs, IVST and LVMI in B allele of Bsm I increased significantly. Fok I, Apa I and Taq I polymorphisms have no significant difference between MHD with LVH and without LVH. Further study showed that VDR expression level decreased significantly in MHD patients with LVH, and the B allele was positively correlated with VDR Expression. Conclusion VDR Bsm I gene polymorphism may predict cardiovascular disease risk of MDH patients, and provided theoretical basis for early detection and prevention of cardiovascular complications.


Sign in / Sign up

Export Citation Format

Share Document